Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia
Clinical trial NCT06062953 · RECRUITING
Trial details
- NCT number
- NCT06062953
- Sponsor
- Lone Baandrup
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-18
- Primary completion
- 2029-02-28
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.